Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibition
Buchbinder, Elizabeth I, Dutcher, Janice P, Daniels, Gregory A, Curti, Brendan D, Patel, Sapna P, Holtan, Shernan G, Miletello, Gerald P, Fishman, Mayer N, Gonzalez, Rene, Clark, Joseph I, Richart, John M, Lao, Christopher D, Tykodi, Scott S, Silk, Ann W, McDermott, David F
Published in Journal for immunotherapy of cancer (18.02.2019)
Published in Journal for immunotherapy of cancer (18.02.2019)
Get full text
Journal Article
Long-term progression-free survival of patients with metastatic melanoma or renal cell carcinoma following high-dose interleukin-2
Clark, Joseph I, Curti, Brendan, Davis, Elizabeth J, Kaufman, Howard, Amin, Asim, Alva, Ajjai, Logan, Theodore F, Hauke, Ralph, Miletello, Gerald P, Vaishampayan, Ulka, Johnson, Douglas B, White, Richard L, Wiernik, Peter H, Dutcher, Janice P
Published in Journal of investigative medicine (01.04.2021)
Published in Journal of investigative medicine (01.04.2021)
Get full text
Journal Article
Therapy with high-dose Interleukin-2
Miletello, Gerald P, Gonzalez, Rene, Holtan, Shernan G, Richart, John M, Fishman, Mayer N, McDermott, David F, Curti, Brendan D, Patel, Sapna P, Lao, Christopher D, Buchbinder, Elizabeth I, Clark, Joseph I, Dutcher, Janice P, Daniels, Gregory A, Silk, Ann W, Tykodi, Scott S
Published in Journal for immunotherapy of cancer (18.02.2019)
Get full text
Published in Journal for immunotherapy of cancer (18.02.2019)
Journal Article